Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Shilpa Medicare’s Plan For Eylea Biosimilar Spells Ambition, But Path Not Easy
Humira Biosimilar Trial Recruiting
May 02 2022
•
By
Vibha Ravi
Shilpa's Biosimilars Ambitions Could Face Obstacles • Source: Alamy
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from R&D
More from Scrip